Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New protein booster may lead to better DNA vaccines and gene therapy

05.03.2015

Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive and easier to store than traditional vaccines.

Their approach, based on research results published this week in the journal Proceedings of the National Academy of Sciences, improves upon an existing laboratory technique, transfection, widely used to study how cells and viruses work.

Jaquelin Dudley, a professor of molecular biosciences at The University of Texas at Austin, and her team have developed a method for boosting the amounts of certain proteins a host cell produces when genes are delivered by transfection. Coaxing cells to produce novel proteins, such as those associated with viruses, is a key feature of DNA vaccines. Dudley's method causes cells to produce novel proteins at levels 5 to 20 times as high as with previous methods.

The researchers suggest that their finding might lead to better DNA vaccines, a relatively new method of vaccination that health experts say would increase vaccination rates, especially in the developing world. Whereas traditional vaccines train the body to attack viruses by introducing weakened forms of the virus, a DNA vaccine works differently, using a bit of DNA specified by a virus to prompt the production of proteins that lead to immunity.

By boosting the amount of proteins produced by the hosts' cells, Dudley's new method might invoke a stronger immune response in patients receiving a DNA vaccine. And, by making smaller vaccine doses possible, it might also reduce the risk that the patient's immune system would inadvertently attack healthy host cells.

The scientists' discovery could also help advance another experimental approach: gene therapies, which treat genetic disorders by replacing or disrupting genes that aren't working properly. Gene therapies targeting Parkinson's, hemophilia, leukemia, cystic fibrosis and many other diseases are being developed, but gene therapies have proved difficult, as they sometimes induce a cancer or trigger an immune response against cells with the introduced genes. The new method for boosting novel protein production might prevent these effects by allowing the insertion of smaller amounts of DNA.

The method for boosting production of novel proteins in a host cell was discovered by accident. Dudley and her team were attempting to understand how mouse mammary tumor virus (MMTV), a virus related to HIV that causes breast cancer and leukemia, manipulates an infected host cell to keep the host's immune system from attacking it.

A bit of genetic material that was expected to produce lower levels of a certain protein instead caused cells to produce a lot more of it.

"Everything in the literature would indicate that something abnormal had happened," said Dudley. "But we went back and used several different detection methods to show that what we observed was real."

According to conventional wisdom, when a cell detects the presence of foreign DNA such as the one the researchers introduced, it shuts down production of proteins to prevent the spread of viruses.

"What we've described is that introducing these DNAs leads to a different detection system in the cell that, instead of shutting down protein expression, increases expression," said Dudley.

When the researchers combined this protein-boosting DNA with genes for other novel proteins and introduced them into host cells, those proteins were also produced at a much higher rate than with traditional methods of delivering genes. Dudley suggests that including this extra bit of genetic material could be applied to a wide range of research problems to increase the production of specific proteins within cells.

###

Dudley's co-authors are Yongqiang Gou, Hyewon Byun, Adam E. Zook, Gurvani B. Singh, Andrea K. Nash and Mary M. Lozano.

This research was supported by the National Institutes of Health.

Read the paper "Retroviral vectors elevate coexpressed protein levels in trans through cap-dependent translation": http://www.pnas.org/content/early/2015/03/02/1420477112.full.pdf+html

Media Contact

Marc Airhart
mairhart@austin.utexas.edu
512-232-1066

 @texasscience

http://www.utexas.edu

Marc Airhart | EurekAlert!

More articles from Life Sciences:

nachricht Fine organic particles in the atmosphere are more often solid glass beads than liquid oil droplets
21.04.2017 | Max-Planck-Institut für Chemie

nachricht Study overturns seminal research about the developing nervous system
21.04.2017 | University of California - Los Angeles Health Sciences

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>